DAVID GRANOVSKY

Jordanian Stem Cell Co. Acquires Stem Cell Technology From Stemedica

In BUSINESS OF STEM CELLS on September 7, 2009 at 5:34 pm

The Jordanian Stem Cell Company Acquires Stem Cell Technology

From Stemedica International S.A.Posted on: Sunday, 6 September 2009, 23:01 CDTSAN DIEGO, Sept. 7 /PRNewswire/

Stemedica Cell Technologies, Inc., “Stemedica”, a world leader in stem cell research and manufacturing, announced the signing of an agreement today for its breakthrough stem cell and related technology. The Jordanian Stem Cell Company has signed a five year multi-million dollar agreement to purchase the technology from Stemedica’s wholly-owned subsidiary, Stemedica International, S.A.

The signing ceremony took place at the European Burns Association Congress in Lausanne, Switzerland.”This is an important day for Stemedica International,” said Frank Schuller, PhD, Stemedica International’s Chairman. “This is a real testament to the quality and integrity of our products and the experience, dedication and professionalism of our team.”

The signing ceremony was attended by Mr. Sam Alkhass, Chief Executive Officer of the Jordanian Stem Cell Company as well as several representatives from Stemedica, including Dr. Schuller; Mark Tager, MD, Executive for Stemedica’s Dermatological Operations; Alex Kharazi, MD, PhD, Stemedica’s Vice President for Research and Manufacturing; and, Riccardo Nisato, MBA, PhD, Director of Manufacturing and Business Development, Stemedica International S.A.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: